TNFRSF11B and breast carcinoma: OPG is expressed in 40% of breast cancers but not in normal breast tissue, and the TRAIL sensitive breast cancer cell line MDA-MB-436 produces sufficient levels of OPG to inhibit TRAIL-induced apoptosis in vitro [17].